Leafly Inc. (LFLYW)
0.01
0.00 (0.00%)
At close: Mar 17, 2025, 12:28 PM
Company Description
Leafly Holdings, Inc. owns and operates an online cannabis information resource for medical marijuana patients and seasoned consumers.
The company's platform provides information on cannabis flowers, topicals, edibles, concentrates, and other products; medical dispensaries, recreational stores, and doctors; and strains.
It also connects with interested cannabis consumers and industry professionals.
Leafly Holdings, Inc. was founded in 2010 and is based in Seattle, Washington with additional offices in Austin, Texas; Baltimore, Maryland; Washington, District of Columbia; Berlin, Germany; and Toronto, Canada.
Leafly Inc.

Country | United States |
IPO Date | Feb 7, 2022 |
Industry | Medical - Pharmaceuticals |
Sector | Healthcare |
Employees | 204 |
CEO | Yoko Miyashita |
Contact Details
Address: 600 1st Ave Seattle, Washington United States | |
Website | https://www.leafly.com |
Stock Details
Ticker Symbol | LFLYW |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001785592 |
CUSIP Number | 52178J113 |
ISIN Number | US52178J1135 |
Employer ID | 00-0000000 |
SIC Code | 7372 |
Key Executives
Name | Position |
---|---|
Yoko Miyashita | Pres, Chief Executive Officer & Director |
Deidre Boulware | Chief People Officer |
Suresh Krishnaswamy | Chief Financial Officer |
Carlos Pinto | Chief Commercial Officer |
David Cotter | Chief Product Officer |
Jeff Oberlander | Senior Vice President of Engineering |
Laura Morarity | Senior Vice President of Marketing & Communications |
Rebecca Warner | Senior Vice President of Sales |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 14, 2025 | 8-K | Current Report |
Mar 13, 2025 | S-8 POS | Filing |
Mar 13, 2025 | S-8 POS | Filing |
Mar 13, 2025 | S-8 POS | Filing |
Mar 12, 2025 | 25 | Filing |
Mar 12, 2025 | S-8 POS | Filing |
Mar 12, 2025 | POS AM | Filing |
Mar 07, 2025 | 4 | Filing |
Mar 07, 2025 | 4 | Filing |
Feb 18, 2025 | 8-K | Current Report |